Tag: Medicare
-

Trump Administration Secures Deal to Lower GLP-1 Drug Prices for Medicare and Other Americans
Trump Administration Negotiates Lower GLP-1 Prices The Trump administration announced new price relief for GLP-1 medications, a class of diabetes and weight-loss drugs that has drawn sharp attention for its rising costs. Through negotiations with pharmaceutical giants Novo Nordisk and Eli Lilly, the administration outlined deals intended to reduce out-of-pocket expenses for Medicare beneficiaries and…
-

Older Adults in Nursing Homes Face Higher Seizure Risk When Taking Tramadol With Certain Antidepressants
New Findings Spotlight Drug Interaction risk for older adults A study published on October 8, 2025, in Neurology®, the journal of the American Academy of Neurology, highlights a modest but measurable increase in seizure risk when the pain medicine tramadol is prescribed alongside certain antidepressants in older adults living in nursing homes. While the research…
-

Billing rates remain low as GPs spend longer with patients, survey finds
Longer consultations, lower per-minute rebates Australian GPs are increasingly dedicating more time to each patient, particularly for mental health issues, while the financial incentives of time-based care push the system toward what practitioners call “six-minute medicine.” A recent Royal Australian College of General Practitioners (RACGP) survey highlights the tension between the demand for thorough, empathetic…
-

Low Billing Rates Push GPs to Spend More Time with Patients
GPs stretched thin as time-based care clashes with patient needs Australian general practitioners are spending more time with patients, especially for mental health and complex care, while billing structures struggle to keep pace. A Royal Australian College of GPs (RACGP) survey highlights a growing gap between the hours GPs dedicate to patients and the rebates…

